首页> 外文学位 >Development of an extended release naproxen sodium matrix tablet and evaluation of the effects of various fillers and additives on drug release kinetics.
【24h】

Development of an extended release naproxen sodium matrix tablet and evaluation of the effects of various fillers and additives on drug release kinetics.

机译:萘普生钠缓释片的研制以及对各种填充剂和添加剂对药物释放动力学的影响的评估。

获取原文
获取原文并翻译 | 示例

摘要

Hydroxypropyl methyl cellulose (HPMC) has been used as a hydrophilic matrix system in extended release formulations. Limited work has been performed and published on hydroxypropyl cellulose (HPC) as a hydrophilic matrix system. This work is intended to develop an extended release naproxen sodium tablet using either hypromellose or hydroxypropyl cellulose as rate controlling polymers and to elucidate the effect of water insoluble (microcrystalline cellulose) and water soluble fillers (lactose monohydrate) as well as insoluble additives (corn starch and pregelatinized starch) on the rate and mechanism of drug release from the matrix.;The naproxen sodium-hypromellose formulation with drug to polymer ratio 1:0.38 when prepared by dry blending yielded an extremely poor flow (Hausner ratio: 1.65) and very low bulk density (0.33 g/mL) whereas upon granulation with IPA, it yielded a bulk density of 0.41g/mL and Hausner ratio of 1.38 which shows the improvement in the physical properties as compared to that of dry blend. Hence, the hypromellose matrix formulations for naproxen sodium tablets were prepared by wet granulation with isopropyl alcohol (IPA). The percent naproxen release from the tablets with drug to polymer ratio of 1:0.38 and microcrystalline cellulose (26% w/w) as filler after 4, 8 and 12 hours were 35%, 59% and 78%. Similarly, the percent naproxen sodium release from tablets with drug to polymer ratio of 1:0.38 and lactose monohydrate (26% w/w) as filler were 43%, 63% and 83%. The results demonstrated that there was no significant difference (F2 value = 59.28) between the release rates from the hypromellose formulations with lactose monohydrate (soluble) or microcrystalline cellulose (insoluble) as fillers.;The wet granulation approach with IPA when applied to hydroxypropyl cellulose (HPC) blend yielded a rubbery mass after drying. Hence, the hydroxypropyl cellulose formulations for naproxen sodium with drug to polymer ratio of 1:0.38 were prepared by dry blending process by adding microcrystalline cellulose or lactose monohydrate at 26% w/w. The final blend of hydroxypropyl cellulose tablets with drug to polymer ratio of 1:0.38 prepared by dry blending yielded a bulk density of 0.42 g/mL and Hausner ratio of 1.50. The percent naproxen sodium release from the HPC tablets with drug to polymer ratio of 1:0.38 and microcrystalline cellulose (26% w/w) after 4, 8 and 12 hours were 51%, 81% and 99% as compared to 50%, 89% and 97% from HPC tablets with drug to polymer ratio of 1:0.38 and lactose monohydrate (26% w/w) as filler. This demonstrated that there no significant difference (F2 value = 72.06) between the release rates from hydroxypropyl cellulose formulations with lactose monohydrate (soluble) or microcrystalline cellulose (insoluble) as fillers.;The release rate from reference formulation with naproxen sodium (51.6% w/w), hydroxypropyl cellulose (20% w/w) and microcrystalline cellulose (26% w/w) as filler was significantly affected when corn starch and pregelatinized starch were added as additives at 1%, 5% and 10% levels. The percent naproxen sodium release after 4, 8 and 12 hours from the tablets with corn starch (10% w/w) as additive were 48%, 76%, 90 % and with pregelatinized starch (10% w/w) as additive were 43%, 68% and 89% as compared to 51%, 81% and 99% from the reference formulation. The comparatively higher retarding effect of pregelatinized starch on the drug release can be attributed to the presence of approximately 20% of gelatinous (gum) part in it which acts synergistically with the gel formed by hydroxypropyl cellulose.;The percent naproxen sodium release form hydroxypropyl cellulose tablets with corn starch (1%, 5% and 10% w/w) and pregelatinized starch (1%, 5% and 10% w/w) as additives to the reference formulation were applied to various kinetic models like Higuchi equation, Power law. First order release equation and Hixson Crowell equation. The Higuchi constant 'k' value obtained from tablets with corn starch (10% w/w) and pregelatinized starch (10% w/w) were 29.642 and 27.141 respectively as compared to 30.173 from reference formulation. The release exponent 'n' of power law from tablets with corn starch (10% w/w) and pregelatinized starch (10% w/w) were 0.6651 and 0.6841 respectively as compared to 0.6935 of reference formulation. The comparative decrease in the higuchi constant 'k' and increase in value of release exponent 'n' from the power law for dissolution rate from the formulations with the increasing amount of corn starch and pregelatinized starch as additives to the reference formulation indicates that the release rate of naproxen sodium decreases with the increase in amount of insoluble additives. The 'n values' obtained upon application of dissolution values to Power law equation with r2 value ranging from 0.9925 to 0.9962 indicates that the naproxen sodium release from the formulations with insoluble additives at different levels is by anomalous path indicating existence of two mechanisms, drug diffusion and polymer relaxation.Thus it can be inferred that naproxen sodium release rate from the hydrophilic matrix can be modulated by varying the amount of insoluble additives in the formulation.
机译:羟丙基甲基纤维素(HPMC)已在延长释放制剂中用作亲水性基质系统。在羟丙基纤维素(HPC)上作为亲水性基质体系已经完成并发表了有限的研究成果。这项工作旨在开发使用羟丙甲纤维素或羟丙基纤维素作为速率控制聚合物的萘普生钠缓释片,并阐明水不溶性(微晶纤维素)和水溶性填充剂(一水合乳糖)以及不溶性添加剂(玉米淀粉)的作用和预糊化淀粉)对药物从基质中释放的速率和机理的影响;通过干混制备的萘普生钠-羟丙甲纤维素制剂(药物与聚合物的比例为1:0.38)产生的流动性极差(豪斯纳比:1.65)且非常低体积密度(0.33 g / mL),而用IPA造粒后,其体积密度为0.41g / mL,Hausner比为1.38,与干混物相比,物理性能有所改善。因此,用于萘普生钠片剂的羟丙甲纤维素基质制剂是通过用异丙醇(IPA)湿法制粒制备的。在药物,聚合物比为1:0.38和微晶纤维素(26%w / w)作为填充剂后4、8和12小时后,萘普生从片剂中释放的百分比分别为35%,59%和78%。类似地,从药物与聚合物之比为1:0.38的乳糖和一水合乳糖(26%w / w)作为填充剂的片剂中萘普生钠的释放百分比分别为43%,63%和83%。结果表明,以乳糖一水合物(可溶性)或微晶纤维素(不溶性)为填充剂的羟丙甲纤维素制剂的释放速率之间无显着差异(F2值= 59.28);当应用于羟丙基纤维素时,采用IPA的湿法制粒方法(HPC)共混物干燥后产生橡胶状物质。因此,通过干混法,通过以26%w / w添加微晶纤维素或乳糖一水合物,通过干混法制备了用于萘普生钠的羟丙基纤维素制剂,其药物与聚合物的比率为1∶0.38。通过干混制备的药物/聚合物比率为1:0.38的羟丙基纤维素片剂的最终混合物产生的堆积密度为0.42 g / mL,Hausner比率为1.50。在4、8和12小时后,药物与聚合物之比为1:0.38的HPC片剂和微晶纤维素(26%w / w)从萘普生钠中释放的百分比分别为51%,81%和99%,而50% HPC片剂的89%和97%,药物与聚合物的比例为1:0.38,乳糖一水合物(26%w / w)作为填充剂。这表明,以乳糖一水合物(可溶性)或微晶纤维素(不溶性)为填充剂的羟丙基纤维素制剂的释放速率之间没有显着差异(F2值= 72.06);萘普生钠(51.6%w)从参考制剂中的释放速率当以1%,5%和10%的水平添加玉米淀粉和预糊化淀粉作为添加剂时,羟丙基纤维素(20%w / w)和微晶纤维素(26%w / w)作为填充剂受到显着影响。用玉米淀粉(10%w / w)作为添加剂的片剂在4、8和12小时后萘普生钠的释放百分比分别为48%,76%,90%,而预糊化淀粉(10%w / w)作为片剂的释放率分别为43%,68%和89%,而参考配方为51%,81%和99%。预糊化淀粉对药物释放的相对较高的阻滞作用可以归因于其中存在约20%的凝胶(胶)部分,该部分与羟丙基纤维素形成的凝胶协同作用。萘普生钠从羟丙基纤维素释放的百分比将玉米淀粉(1%,5%和10%w / w)和预糊化淀粉(1%,5%和10%w / w)作为参考制剂的添加剂的片剂应用于各种动力学模型,例如Higuchi方程,幂律。一阶释放方程式和Hixson Crowell方程式。从具有玉米淀粉(10%w / w)和预糊化淀粉(10%w / w)的片剂获得的Higuchi常数“ k”值分别为29.642和27.141,而参考制剂为30.173。与参考制剂的0.6935相比,具有玉米淀粉(10%w / w)和预糊化淀粉(10%w / w)的片剂的幂律的释放指数“ n”分别为0.6651和0.6841。玉米淀粉和预糊化淀粉作为添加剂添加到参考配方中时,配方的溶出度相对于幂律的hi口常数“ k”相对降低,释放指数“ n”的值增大,表明该配方的释放萘普生钠的比例随不溶性添加剂量的增加而降低。将溶出度值应用于幂定律方程,其r2值在0.9925至0.9962之间时获得的“ n值”表明,具有不同水平的不溶性添加剂的萘普生钠从制剂中的释放是通过异常路径表明存在两种机制,即药物扩散因此可以推断出萘普生钠从亲水性基质中的释放速率可以通过改变制剂中不溶性添加剂的量来调节。

著录项

  • 作者

    Patel, Maulik R.;

  • 作者单位

    Long Island University, The Brooklyn Center.;

  • 授予单位 Long Island University, The Brooklyn Center.;
  • 学科 Health Sciences Pharmacy.
  • 学位 M.S.
  • 年度 2011
  • 页码 81 p.
  • 总页数 81
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号